Humanigen, Inc.

@humanigen

Humaneered® Monoclonal Antibodies to Neutralize Cytokine Storm Induced by SARS-CoV-2 (COVID-19), CAR-T, and GvHD. …

533 Airport Blvd #400, Burlingame, CA 94010, USA
humanigen.com
Joined November 2018
35 Photos and videos Photos and videos

Tweets

You blocked @humanigen

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @humanigen

  1. Jan 29

    We’ve just completed enrollment in our phase 3 study of lenzilumab in hospitalized patients with COVID-19, marking a significant milestone for us. We plan to announce top-line data in March.

    13 replies 13 retweets 70 likes
    Undo
  2. Jan 28

    Chief Scientific Officer Dale Chappell provides the scientific rationale for in treating patients hospitalized with COVID-19 as part of “Lenzilumab, , and ,” a Q&A series featuring Humanigen leadership and community members.

    12 replies 11 retweets 47 likes
    Undo
  3. Retweeted
    Jan 27

    : Aji Bio-Pharma is pleased to be expanding their manufacturing agreement with Humanigen for the fill finish supply of lenzilumab, which is one of the few Phase 3 treatment options in development for patients hospitalized with -19.

    1 reply 6 retweets 27 likes
    Undo
  4. Jan 27

    Together with , we’re proud to announce the expansion of our manufacturing agreement for the fill finish supply of lenzilumab. Learn more:

    3 replies 5 retweets 38 likes
    Undo
  5. Retweeted
    Jan 25

    We have signed a new CDMO agreement to support the drug product manufacturing for ’s Phase 3 COVID-19 therapeutic candidate, lenzilumab™. Read the full announcement here: .

    8 retweets 39 likes
    Undo
  6. Jan 25

    We are pleased to offer the option to sign up for investor email alerts for news releases, upcoming events, stock quotes, and more. Sign up here:

    1 reply 4 retweets 38 likes
    Undo
  7. Jan 25

    Humanigen and announced partnership leveraging support to manufacture lenzilumab in preparation for the next phase of growth. Learn more:

    6 replies 7 retweets 41 likes
    Undo
  8. Jan 22

    Our own Dr. Cameron Durrant kicks off “Lenzilumab, , and ,” a Q&A series we are hosting to discuss developments around our phase 3 trial and the broader treatment landscape. We start with: What is Humanigen? Stay tuned for more soon.

    5 replies 9 retweets 45 likes
    Undo
  9. Jan 22

    Today, Humanigen announced the addition of to our expanded CRADA with the as we advance the development of lenzilumab for . Learn more:

    1 reply 11 retweets 42 likes
    Undo
  10. Jan 15

    Thank you to all who joined for our discussion with and ’s Cosme Ordonez as part of the . , click here to watch the conversation:

    8 replies 6 retweets 33 likes
    Undo
  11. Jan 14

    our CEO Dr. Cameron Durrant discussed our Phase 3 progress and commercial plan in the context of the rapidly changing treatment, vaccination & competitive landscape at the conference. Register and watch here:

    5 retweets 38 likes
    Undo
  12. Jan 14

    Today we share updates on our program, pipeline & more in a fireside chat with ‘s Cosme Ordonez at ’s . Join our session live at 1pm ET.

    4 retweets 31 likes
    Undo
  13. Jan 11

    Please review the journal pre-proof from Mayo Clinic Proceedings regarding lenzilumab.

    6 replies 15 retweets 49 likes
    Undo
  14. Jan 10

    We’re pleased to announce a partnership with as we continue commercialization preparation to ensure ready access to lenzilumab pending a potential EUA. Learn more:

    10 replies 13 retweets 67 likes
    Undo
  15. Jan 5

    Minnesotans, nearly 90% of patients are at risk for a deadly complication called ? Learn about a clinical trial near you:

    8 replies 3 retweets 22 likes
    Undo
  16. Jan 4

    Los Angelans, nearly 90% of patients are at risk for a deadly complication called ? Learn about a clinical trial near you:

    5 replies 3 retweets 26 likes
    Undo
  17. Jan 2

    People of Irvine, nearly 90% of patients are at risk for a deadly complication called ? Learn about a clinical trial near you:

    4 replies 2 retweets 29 likes
    Undo
  18. 31 Dec 2020

    Dallasites, nearly 90% of patients are at risk for a deadly complication called ? Learn about a clinical trial near you:

    1 reply 4 retweets 31 likes
    Undo
  19. 28 Dec 2020

    Charlotteans, nearly 90% of patients are at risk for a deadly complication called ? Learn about a clinical trial near you:

    5 replies 4 retweets 29 likes
    Undo
  20. 23 Dec 2020

    Get to know Dr. Dale Chappell, our Chief Scientific Officer, in this informative episode of the Talks . Listen to hear Dale discuss his background, Humanigen’s history & how we’re using Lenzilumab to target cytokine storm:

    5 replies 4 retweets 37 likes
    Undo

@humanigen hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·